Literature DB >> 33258970

Use of insulin pump therapy is associated with reduced hospital-days in the long-term: a real-world study of 48,756 pediatric patients with type 1 diabetes.

Marie Auzanneau1,2, Beate Karges3, Andreas Neu4, Thomas Kapellen5, Stefan A Wudy6, Corinna Grasemann7, Gabriele Krauch8, Eva Maria Gerstl9, Gerhard Däublin10, Reinhard W Holl11,12.   

Abstract

In pediatric diabetes, insulin pump therapy is associated with less acute complications but inpatient pump education may lead to more hospital days. We investigated the number of hospital days associated with pump vs. injection therapy between 2009 and 2018 in 48,756 patients with type 1 diabetes < 20 years of age from the German Diabetes Prospective Follow-up Registry (DPV). Analyses were performed separately for hospitalizations at diagnosis (hierarchical linear models adjusted for sex, age, and migration), and for hospitalizations in the subsequent course of the disease (hierarchical Poisson models stratified by sex, age, migration, and therapy switch). At diagnosis, the length of hospital stay was longer with pump therapy than with injection therapy (mean estimate with 95% CI: 13.6 [13.3-13.9] days vs. 12.8 [12.5-13.1] days, P < 0.0001), whereas during the whole follow-up beyond diagnosis, the number of hospital days per person-year (/PY) was higher with injection therapy than with pump therapy (4.4 [4.1-4.8] vs. 3.9 [3.6-4.2] days/PY), especially for children under 5 years of age (4.9 [4.4-5.6] vs. 3.5 [3.1-3.9] days/PY).Conclusions: Even in countries with hospitalizations at diabetes diagnosis of longer duration, the use of pump therapy is associated with a reduced number of hospital days in the long-term. What is known: • In pediatric diabetes, insulin pump therapy is associated with better glycemic control and less acute complications compared with injection therapy. • However, pump therapy implies more costs and resources for education and management. What is new: • Even in countries where pump education is predominantly given in an inpatient setting, the use of pump therapy is associated with a reduced number of hospital days in the long-term. • Lower rates of hospitalization due to acute complications during the course of the disease counterbalance longer hospitalizations due to initial pump education.

Entities:  

Keywords:  Children; Hospital days; Hospitalization; Insulin pump therapy; Type 1 diabetes

Mesh:

Substances:

Year:  2020        PMID: 33258970      PMCID: PMC7813690          DOI: 10.1007/s00431-020-03883-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  23 in total

1.  Hospitalization in Pediatric Diabetes: A Nationwide Analysis of all Admission Causes for Germany in 2015.

Authors:  Marie Auzanneau; Joachim Rosenbauer; Andrea Icks; Beate Karges; Andreas Neu; Ralph Ziegler; Wolfgang Marg; Thomas Kapellen; Paul-Martin Holterhus; Reinhard W Holl
Journal:  Exp Clin Endocrinol Diabetes       Date:  2019-08-19       Impact factor: 2.949

Review 2.  Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents.

Authors:  Andreas Neu; Jutta Bürger-Büsing; Thomas Danne; Axel Dost; Martin Holder; Reinhard W Holl; Paul-Martin Holterhus; Thomas Kapellen; Beate Karges; Olga Kordonouri; Karin Lange; Susanne Müller; Klemens Raile; Roland Schweizer; Simone von Sengbusch; Rainer Stachow; Verena Wagner; Susanna Wiegand; Ralph Ziegler
Journal:  Exp Clin Endocrinol Diabetes       Date:  2019-12-20       Impact factor: 2.949

3.  Real-World Costs of Continuous Insulin Pump Therapy and Multiple Daily Injections for Type 1 Diabetes: A Population-Based and Propensity-Matched Cohort From the Swedish National Diabetes Register.

Authors:  Emilie Toresson Grip; Ann-Marie Svensson; Mervete Miftaraj; Björn Eliasson; Stefan Franzén; Soffia Gudbjörnsdottir; Katarina Steen Carlsson
Journal:  Diabetes Care       Date:  2019-01-31       Impact factor: 19.112

4.  Site of initial diabetes education does not affect metabolic outcomes in children with T1DM.

Authors:  Ksenia N Tonyushkina; Paul F Visintainer; Christopher F Jasinski; Thomas L Wadzinski; Holley F Allen
Journal:  Pediatr Diabetes       Date:  2013-08-27       Impact factor: 4.866

5.  Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: The pumpkin multicenter randomized controlled trial.

Authors:  Esther Mueller-Godeffroy; Reinhard Vonthein; Carmen Ludwig-Seibold; Bettina Heidtmann; Claudia Boettcher; Miriam Kramer; Nicole Hessler; Doerte Hilgard; Eggert Lilienthal; Andreas Ziegler; Verena M Wagner
Journal:  Pediatr Diabetes       Date:  2018-10-10       Impact factor: 4.866

6.  Insulin pump initiation and education for children and adolescents - a qualitative study of current practice in New Zealand.

Authors:  Yasmin H AbdulAziz; Hesham S Al-Sallami; Esko Wiltshire; Jenny Rayns; Jinny Willis; Joanna McClintock; Natalie Medlicott; Benjamin J Wheeler
Journal:  J Diabetes Metab Disord       Date:  2019-02-12

7.  Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children.

Authors:  Laura M Jacobsen; Helena E Larsson; Roy N Tamura; Kendra Vehik; Joanna Clasen; Jay Sosenko; William A Hagopian; Jin-Xiong She; Andrea K Steck; Marian Rewers; Olli Simell; Jorma Toppari; Riitta Veijola; Anette G Ziegler; Jeffrey P Krischer; Beena Akolkar; Michael J Haller
Journal:  Pediatr Diabetes       Date:  2019-01-29       Impact factor: 3.409

8.  Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study.

Authors:  Isabelle Steineck; Jan Cederholm; Björn Eliasson; Araz Rawshani; Katarina Eeg-Olofsson; Ann-Marie Svensson; Björn Zethelius; Tarik Avdic; Mona Landin-Olsson; Johan Jendle; Soffia Gudbjörnsdóttir
Journal:  BMJ       Date:  2015-06-22

9.  Cost-effectiveness and cost-utility analyses of hospital-based home care compared to hospital-based care for children diagnosed with type 1 diabetes; a randomised controlled trial; results after two years' follow-up.

Authors:  Irén Tiberg; Björn Lindgren; Annelie Carlsson; Inger Hallström
Journal:  BMC Pediatr       Date:  2016-07-15       Impact factor: 2.125

10.  Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008-2012: association with hemoglobin A 1c and treatment modality.

Authors:  N H Birkebaek; A K Drivvoll; K Aakeson; R Bjarnason; A Johansen; U Samuelsson; T Skrivarhaug; A V Thorsson; J Svensson
Journal:  BMJ Open Diabetes Res Care       Date:  2017-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.